
Why a 25-cent pill is being sold to cancer patients for nearly $1,000
Apple News In Conversation
00:00
Decoding Insulin Price Caps
This chapter analyzes the introduction of an insulin price cap under the Inflation Reduction Act and the political dynamics surrounding its credit attribution. It explores the implications for drug affordability, patient loyalty, and the broader challenges of healthcare pricing in the United States, emphasizing the need for reform in Medicare's pricing negotiations.
Transcript
Play full episode